Skip to content
ZANU80

Drawing based on the label description. No photo yet.

“Capsules: Each 80 mg capsule is a size 0, white to off-white opaque capsule marked with "ZANU 80" in black ink”

ZANU 80 pill

Pill with imprint ZANU 80 is white, capsule, 22 mm and has been identified as Zanubrutinib 80 mg. It is used for mantle-cell lymphoma. It is supplied by Beone Medicines Usa, Inc.

Zanubrutinib 80 mg

Imprint
ZANU 80
Strength
80 mg
Used for
Mantle-cell lymphoma
Color
White
Shape
Capsule / oblong
Size
22 mm
Score
No score line
Form
Capsule
Manufacturer
Beone Medicines Usa, Inc
Drug class
Cancer medicine (kinase inhibitor)
NDC
72579-011, 72579-011-02, 72579-011-01

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Zanubrutinib pills and guides

What is Zanubrutinib used for?

Zanubrutinib is used for mantle-cell lymphoma.

Medicine type
Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label

Mantle Cell Lymphoma

BRUKINSA is indicated for the treatment of adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.

This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Waldenström's Macroglobulinemia

BRUKINSA is indicated for the treatment of adult patients with Waldenström's macroglobulinemia (WM).

Marginal Zone Lymphoma

BRUKINSA is indicated for the treatment of adult patients with relapsed or refractory marginal zone lymphoma (MZL) who have received at least one anti–CD20-based regimen.

This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

BRUKINSA is indicated for the treatment of adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).

Follicular Lymphoma

BRUKINSA is indicated for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL), in combination with obinutuzumab, after two or more lines of systemic therapy.

This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

From the FDA-approved label on DailyMed (published Sep 14, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows ZANU 80. The parts can be split between the two sides, so turn the pill over and check both.
  • It is white, capsule, 22 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Brukinsa.

Ingredients

Active: Zanubrutinib

Inactive: Silicon Dioxide, Croscarmellose Sodium, Magnesium Stearate, Microcrystalline Cellulose, Sodium Lauryl Sulfate, Gelatin, Unspecified, Titanium Dioxide, Ferrosoferric Oxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Zanubrutinib pills